COST-EFFECTIVENESS OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH RIVAROXBAN IN AUSTRALIA

被引：0
|
作者：
Gao, L. [1 ]
Li, S. C. [1 ]
机构：
[1] Univ Newcastle, Callaghan, NSW 2308, Australia
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.255
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV30
引用
收藏
页码：A760 / A760
页数：1
相关论文
共 50 条
  • [31] Assessing the cost-effectiveness of newer therapies in non-ST elevation acute coronary syndrome patients
    Eisenstein, EL
    Peterson, ED
    Jollis, JG
    Tardiff, BE
    Knight, JD
    Mark, DB
    CIRCULATION, 1997, 96 (08) : 1011 - 1011
  • [32] Long-term health outcomes and cost-effectiveness of coronary CT angiography in patients with suspicion for acute coronary syndrome
    Goehler, Alexander
    Mayrhofer, Thomas
    Pursnani, Amit
    Ferencik, Maros
    Lumish, Heidi S.
    Barth, Cordula
    Karady, Julia
    Chow, Benjamin
    Truong, Quynh A.
    Udelson, James E.
    Fleg, Jerome L.
    Nagurney, John T.
    Gazelle, G. Scott
    Hoffmann, Udo
    JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2020, 14 (01) : 44 - 54
  • [33] Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome
    Kazi, Dhruv S.
    Garber, Alan M.
    Shah, Rashmee U.
    Dudley, R. Adams
    Mell, Matthew W.
    Rhee, Ceron
    Moshkevich, Solomon
    Boothroyd, Derek B.
    Owens, Douglas K.
    Hlatky, Mark A.
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (04) : 221 - 232
  • [34] A COST-EFFECTIVENESS ANALYSIS OF MULITI-GENE PHARMACOGENETIC TESTING IN ACUTE CORONARY SYNDROME PATIENTS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION
    Dong, O.
    Lee, C. R.
    Wheeler, S. B.
    Voora, D.
    Dusetzina, S. B.
    Wiltshire, T.
    VALUE IN HEALTH, 2018, 21 : S6 - S6
  • [35] Cost-effectiveness analysis of increased use of percutaneous coronary intervention in acute coronary syndrome patients from 6 European countries
    Degano, I. Roman
    Forne, C.
    Ferrieres, J.
    Kirchberger, I.
    Farmakis, D.
    Tavazzi, L.
    Brosa, M.
    Marrugat, J.
    EUROPEAN HEART JOURNAL, 2018, 39 : 274 - 274
  • [36] Cost-effectiveness of intensive atorvastatin therapy in patients following acute coronary syndromes
    Koren, MJ
    Schwartz, SJ
    Drummond, MF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 347A - 347A
  • [37] Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes The ODYSSEY OUTCOMES Trial
    Bhatt, Deepak L.
    Briggs, Andrew H.
    Reed, Shelby D.
    Annemans, Lieven
    Szarek, Michael
    Bittner, Vera A.
    Diaz, Rafael
    Goodman, Shaun G.
    Harrington, Robert A.
    Higuchi, Keiko
    Joulain, Florence
    Jukema, J. Wouter
    Li, Qian H.
    Mahaffey, Kenneth W.
    Sanchez, Robert J.
    Roe, Matthew T.
    Lopes, Renato D.
    White, Harvey D.
    Zeiher, Andreas M.
    Schwartz, Gregory G.
    Steg, Ph. Gabriel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (18) : 2297 - 2308
  • [38] Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
    Grima, Daniel T.
    Brown, Stephen T.
    Kamboj, Laveena
    Bainey, Kevin R.
    Goeree, Ron
    Oh, Paul
    Ramanathan, Krishnan
    Goodman, Shaun G.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 49 - 62
  • [39] COST EFFECTIVENESS OF TIROFIBAN IN ACUTE CORONARY SYNDROME
    Lee, Y. C.
    Mueller, A.
    Ryder, S.
    Kleijnen, J.
    Armstrong, N.
    VALUE IN HEALTH, 2012, 15 (07) : A473 - A473
  • [40] Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany
    Theidel, Ulrike
    Asseburg, Christian
    Giannitsis, Evangelos
    Katus, Hugo
    CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (06) : 447 - 458
12345